DOI QR코드

DOI QR Code

Protocol for Systematic Review of Controlled Trials of Korean and Chinese Herbal Treatments for Stroke

  • Lee, Ju-Ah (Department of Korean Internal Medicine, College of Korean Medicine, Gachon University) ;
  • Choi, Tae-Young (Clinical Research Division, Korea Institute of Oriental Medicine) ;
  • Lee, Myeong Soo (Clinical Research Division, Korea Institute of Oriental Medicine) ;
  • Ko, Mimi (KM Fundamental Research Division, Korea Institute of Oriental Medicine) ;
  • Kang, Byoung-Kab (KM Fundamental Research Division, Korea Institute of Oriental Medicine) ;
  • Liu, Huan (Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences) ;
  • Jiang, Jun-Jie (Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences) ;
  • Li, Yuan-Yuan (Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences)
  • Received : 2017.10.21
  • Accepted : 2017.11.09
  • Published : 2017.11.30

Abstract

Background: Many stroke patients receive traditional medical care in Korea and China. Stroke patients comprise the largest proportion of inpatients in traditional Korean medicine and traditional Chinese medicine hospitals. The purpose of this study is to identify the types and effects of Chinese medicine widely used in China and Korea, and to apply them to future studies of stroke. Methods: Nine Korean and Chinese databases will be surveyed for clinical studies of herbal medicines for stroke, published between the inception of the database and August 2017. Clinical studies of decoctions or modified decoctions will be included without restriction on study type. The frequencies and patterns of formulas or single herb usage and the any type of herbal medicine utilization will be analyzed. Dissemination: The results of the systematic review will be published in a peer-reviewed journal and disseminated electronically and in print. Updates of the review will be conducted to inform and guide healthcare practices.

Keywords

References

  1. Joo H, Liang D. Economic burden of informal care attributable to stroke among those aged 65 years or older in China. Int J Stroke 2016;12:205-207.
  2. Yang Y, Shi YZ, Zhang N, Wang S, Ungvari GS, Ng CH, et al. The disability rate of 5-year post-stroke and its correlation factors: a national survey in China. PLoS One 2016;11:e0165341. doi: 10.1371/journal.pone.0165341.
  3. Ko MM, Lee JA, Cha MH, Kang BK, Lee MS. Stroke in traditional Korean medicine: a nine-year multicentre community-based study in South Korea. Sci Rep 2016;6:28286. doi: 10.1038/srep28286.
  4. Hung IL, Hung YC, Wang LY, Hsu SF, Chen HJ, Tseng YJ, et al. Chinese herbal products for ischemic stroke. Am J Chin Med 2015;43:1365-1379. https://doi.org/10.1142/S0192415X15500779
  5. Hung YC, Cheng YC, Muo CH, Chiu HE, Liu CT, Hu WL. Adjuvant Chinese herbal products for preventing ischemic stroke in patients with atrial fibrillation. PLoS One 2016;11:e0159333. doi: 10.1371/journal.pone.0159333. eCollection 2016.
  6. Gu Y, Chen J, Shen J. Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets. J Neuroimmune Pharmacol 2014;9:313-339. https://doi.org/10.1007/s11481-014-9525-5
  7. Ferro JM, Bousser MG, Canhao P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis-endorsed by the European Academy of Neurology. Eur J Neurol 2017;24:1203-1213. https://doi.org/10.1111/ene.13381
  8. Lee J, Park E, Lee A, Chang WH, Kim DS, Kim YH. Recovery-related indicators of motor network plasticity according to impairment severity after stroke. Eur J Neurol 2017;24:1290-1299. https://doi.org/10.1111/ene.13377
  9. Nam KW, Kwon HM, Lim JS, Han MK, Lee YS. Clinical relevance of abnormal neuroimaging findings and long-term risk of stroke recurrence. Eur J Neurol 2017;24:1348-1354. https://doi.org/10.1111/ene.13391
  10. Yu X, Yang L, Song R, Jiaerken Y, Yang J, Lou M, et al. Changes in structure and perfusion of grey matter tissues during recovery from ischaemic subcortical stroke: a longitudinal MRI study. Eur J Neurosci 2017;46:2308-2314. https://doi.org/10.1111/ejn.13669
  11. Chen LD, Yang SL. Application of evidence-based medicine in establishment of TCM stroke unit. Zhongguo Zhen Jiu 2006;26:138-140.
  12. Zhao XF, Su SJ, Yun G, Guo YH, Wang S. Mortality and recurrence of vascular disease among stroke patients treated with combined TCM therapy. J Tradit Chin Med 2012;32:173-178. https://doi.org/10.1016/S0254-6272(13)60007-2
  13. Zhao ZX, Wu YN, Peng J. Evolution of the concept of wind stroke of traditional Chinese medicine (TCM). Zhonghua Yi Shi Za Zhi 2009;39:159-163. [In Chinese]
  14. Shen YC, Lu CK, Liou KT, Hou YC, Lin YL, Wang YH, et al. Common and unique mechanisms of Chinese herbal remedies on ischemic stroke mice revealed by transcriptome analyses. J Ethnopharmacol 2015;173:370-382. https://doi.org/10.1016/j.jep.2015.07.018
  15. Yu M, Sun ZJ, Li LT, Ge HY, Song CQ, Wang AJ. The beneficial effects of the herbal medicine Di-Huang-Yin-Zi (DHYZ) on patients with ischemic stroke: a randomized, placebo controlled clinical study. Complement Ther Med 2015;23:591-597. https://doi.org/10.1016/j.ctim.2015.06.003
  16. Hung YC, Cheng YC, Muo CH, Chiu HE, Liu CT, Hu WL. Adjuvant Chinese herbal products for preventing ischemic stroke in patients with atrial fibrillation. PLoS One 2016;11:e0159333. doi: 10.1371/journal.pone.0159333.
  17. Li JH, Chen ZX, Zhang XG, Li Y, Yang WT, Zheng XW, et al. Bioactive components of Chinese herbal medicine enhance endogenous neurogenesis in animal models of ischemic stroke: a systematic analysis. Medicine 2016;95:e4904. doi: 10.1097/MD.0000000000004904.